JP2020155158A - Display device for displaying clinical examination value, server, display method, and program - Google Patents

Abstract

To provide a display device for displaying a clinical examination value, with which it is possible to efficiently grasp the information needed for prescription audit of a prescription prepared for a patient.SOLUTION: Provided is a display device for displaying a clinical examination value, comprising: grouping means for accepting the medicine and clinical examination value written in a prescription and grouping the clinical examination values on the basis of relationship between medicine and clinical examination values; and display means for displaying the grouped clinical examination values distinguishably on a display unit. Grouping in the display device for displaying the clinical examination values means that the clinical examination values displayed by the display device the examination values are the clinical examination values classified into different groups for each medicine.SELECTED DRAWING: Figure 3

Description

The present invention relates to a display device, a server, a display method and a program for displaying clinical test values.

The development of information processing technology has spread widely to medical institutions such as pharmacies that dispense and provide drugs, and is increasing convenience. For example, in medical institutions, computers such as receipt computers that support the creation of receipts (statement of medical fees) have been known for a long time, and it is possible to create receipts without requiring advanced specialized knowledge or complicated calculations. ing. Further, in recent years, a system for electronically managing patient information such as drug history has become widespread.

In the past, the receipt computer and the drug history management system were hardware-independent computers. Therefore, for example, Patent Document 1 describes both functions in a pharmacy computer having a receipt computer function and a drug history management function. A computer for a pharmacy that is effectively linked is disclosed.

Japanese Unexamined Patent Publication No. 2011-118535

By the way, when dispensing a drug to a patient, a prescription audit is conducted to confirm whether there is any doubt about delivering the drug as it is based on the items described in the prescription, patient information, drug history, and the like. In such a prescription audit, clinical laboratory test values that can grasp the condition of the patient's injury or illness and the effect of the drug being taken may be referred to. However, there are many clinical test values, and even if many input clinical test values are displayed indiscriminately, it is not possible to efficiently grasp information on the target injury / illness / drug. As a result, even if information such as clinical test values is displayed for prescription audit, it is not possible to efficiently search for necessary clinical test value information, so that appropriate prescription audit cannot be performed promptly.

The present invention has been made in view of such a situation, and provides a display device and a program for displaying clinical test values capable of efficiently grasping information necessary for prescription audit of a prescription prescribed to a patient. With the goal.

(1) Grouping means for accepting drugs and clinical test values described in the prescription and grouping the clinical test values based on the relationship between the drug and the clinical test values, and grouped clinical test values for each group. A display device for displaying clinical laboratory test values, which comprises a display means for displaying on a display unit in a distinguishable manner.

(2) The grouping is a display device for displaying the clinical test values according to (1), wherein one clinical test value may be classified into a different group for each drug.

(3) The display device for displaying the clinical laboratory test values according to (1) or (2), wherein the grouping is performed for each effect of the drug and side effects of the drug.

(4) The grouping is a display device for displaying the clinical test values according to (3), which may be classified into the side effect section of a drug when the clinical test values are predetermined values.

(5) The display means displays the clinical test value having the relationship with the drug and the clinical test value having no relationship with the drug in response to the acceptance of the selection of the drug. A display device that displays the clinical test values according to any one of (1) to (4).

(6) The display means is a display device for displaying the clinical test value according to any one of (1) to (5), which displays the clinical test value separately at the place where the clinical test value is acquired.

(7) A grouping step that accepts the drug and clinical test value described in the prescription and groups the clinical test value based on the relationship between the drug and the clinical test value, and the grouped clinical test value for each group. A program that causes a computer to execute a display step that is displayed on the display so that it can be distinguished.

To select the drug column, prescription audit-related information column, and intersection column, it is sufficient to accept the selection of any one column and display specific information, select only the drug column, and select only the prescription audit-related information. Selection, selection of only the intersection column, selection of drug column and prescription audit related information column, selection of drug column and prescription audit related information column, selection of prescription audit related information column and intersection column, or selection of drug column and prescription audit related Specific information may be displayed by selecting the information column and the intersection column.

According to the present invention, it is possible to efficiently grasp the information necessary for prescription audit of a prescription prescribed to a patient.

It is a figure which shows the structure of the display system which displays the clinical test value. It is a figure which shows the outline of the drug providing business. It is a block diagram which shows the functional structure of the display device which displays a clinical test value. It is a figure which shows the patient DB of a memory part. It is a figure which shows the clinical examination value DB of a memory part. It is a figure which shows the package insert DB of a storage part. It is a figure which shows an example of the display screen displayed on the display device which displays a clinical test value. It is a figure which shows an example of the display screen displayed on the display device which displays a clinical test value. It is a flowchart which shows the process flow of the display system which displays a clinical test value. It is a block diagram which shows the functional structure of the display device which displays a clinical test value. It is a figure which shows the patient DB of a memory part. It is a figure which shows an example of the display screen displayed on the display device which displays a clinical test value.

Hereinafter, an embodiment of the present invention will be described with reference to the drawings.

[First Embodiment]
[Configuration of display system 100 for displaying clinical test values]
With reference to FIG. 1, the display system 100 for displaying the clinical test values of the present invention includes the administrator device 1, the display devices 2a ... 2n for displaying the clinical test values used by the person in charge on the pharmacy side, and the patient. It is configured to include a display 3 that informs the progress of the drug providing business.

Display devices 2a ... 2n for displaying clinical test values are terminal devices used by persons in charge of each work constituting the drug providing business.
Here, referring to FIG. 2 (1), in the drug providing business, after receiving a prescription from a patient at the counter, the drug is dispensed according to the prescription, and when the final audit confirms that the dispensing is appropriate, It consists of a series of steps such as providing the drug to the patient at the counter. As an example, such drug provision operations are shown in FIG. 2 (2), that is, "reception", "drug history confirmation", "prescription audit", "patient information collection", "dispensing design", "explanation of medication", and "dispensing decision". It can be composed of "dispensing", "final audit", and "drug delivery accounting". Some of these operations can proceed independently of each other, and in the present embodiment, each of these operations is divided by a plurality of persons in charge. For example, among the tasks that make up the drug provision business, pharmacist A is in charge of "reception,""patient information collection,""dispensing," and "drug delivery accounting," and "drug history confirmation,""prescriptionaudit,""dispensingdesign," and "dispensing design." Pharmacist B is in charge of "explanation about medication" and "dispensing decision", and pharmacist C is in charge of "final audit".
In such an embodiment, for example, the display device 2a for displaying the clinical test value is used by the pharmacist A, and the display device 2b for displaying the clinical test value is used by the pharmacist B to display the clinical test value. 2c will be used by pharmacist C. Of course, the display devices 2a ... 2n for displaying the clinical test values may be used not only by one person in charge but also shared by a plurality of persons in charge. Since the configurations of the display devices 2a ... 2n for displaying the clinical test values are basically the same, they may be simply referred to as "display devices 2 for displaying the clinical test values" below.

The administrator device 1 is a terminal device used by an administrator who manages each person in charge and has administrator authority such as expansion, change, restriction, etc. of the function of the display device 2 for displaying clinical test values, and performs various arithmetic processes. It is a general-purpose personal computer equipped with an input unit realized by a keyboard, a touch panel, etc., and a display unit by a display, in addition to a control unit for performing the above and a storage unit for storing various information.

The display device 2 for displaying the clinical test value is intended to support the business in a pharmacy from various aspects, and is realized by a general-purpose personal computer like the administrator device 1. Various programs are installed in the display device 2 that displays such clinical test values, and when the control unit operates according to these programs, in addition to the receipt computer function, drug history management function, and work sharing function, "prescription audit" ”, It exerts a function of displaying clinical test values. The clinical test value is referred to when grasping the state of injury or illness of the patient and the degree of influence of the drug, and refers to a value obtained by qualitatively or quantitatively measuring the components and cells contained in the patient. In pharmacies, it is referred to in order to grasp whether the drug is sufficiently effective and whether side effects of the drug are occurring by "prescription audit".
The administrator device 1 and the display device 2 for displaying clinical test values are connected by a predetermined network line, and cooperate with each other to support a drug providing operation to a patient.

The display 3 is arranged toward the patient who visited the pharmacy, and displays the progress status indicating the progress of the drug providing business to the patient. The display 3 is communicably connected to the administrator device 1 and / or the display device 2 that displays the clinical test values, and the progress status according to the instructions from the administrator device 1 and / or the display device 2 that displays the clinical test values. Is displayed.

[Functional configuration of display device 2 for displaying clinical laboratory test values]
Subsequently, the configuration of the display device 2 for displaying the clinical test values will be described with reference to FIG. The display device 2 for displaying the clinical test value has the reception means 211, the extraction means 212, the grouping means 213, and the display means 214 in the control unit 21, and the patient DB 221 and the patient DB 221 in one area of the storage unit 22. , Clinical laboratory test value DB222 and package insert DB223.

The reception means 211 receives the contents of the prescription and the clinical test value of the patient at a specific visit of the patient, and stores the prescription contents and the clinical test value in the patient DB 221 in association with the patient ID.
Here, the prescription content is information about the content described in the prescription and information generated accompanying the reception of the prescription, for example, specific information of the patient such as the patient's name, a prescription drug indicating the prescribed drug. And the reception date indicating the date when the prescription was accepted by the pharmacy, the initial administration indicating whether the drug described in the prescription was prescribed to the patient for the first time, and the like.
In addition, the clinical test values are, for example, biopsy of the patient's condition such as blood pressure and pulse, and the components / cells possessed by the patient by analyzing samples collected from the patient such as blood glucose level, red blood cell count, urinary protein and γ-GTP. It is stored including the sample test of.
As for the prescription contents and clinical test values received by the receiving means 211, as will be described later, when the extracting means 212 extracts the patient's past prescription contents and clinical test values, or the grouping means 213 groups the clinical test values. It is used when doing so.

The extraction means 212 extracts from the patient DB the types and values of past prescription contents and clinical test values associated with the patient ID of the patient who received the prescription. Further, the extraction means 212 extracts the relationship between the drug contained in the received prescription content and the clinical test value from the clinical test value DB 222 based on the received prescription content and the type and value of the clinical test value.

In addition, the patient DB 221 will be described with reference to FIG. The patient DB 221 is a DB that stores the prescription contents and clinical test values received at the pharmacy, and stores the prescription contents and clinical test values received by the reception means 211 in association with the patient ID. The patient DB 221 has a "patient ID" that stores information that identifies the patient, a "patient name" that stores the patient's name, a "reception date" that stores the date when the prescription was accepted, and a prescription that is the content of the accepted prescription. It is configured to have a "drug" that stores the received drug, a "clinical test value item" that stores the type of clinical test value received, and a "clinical test value" that stores the value of the received clinical test value. Has been done. In the value of the "clinical test value", in addition to a quantitative value such as a specific number, a qualitative value indicating the presence or absence of the clinical test value is stored. For example, the clinical laboratory test value of systolic blood pressure stores a quantitative value of 95 mgHG, which is a specific number, and the clinical laboratory test value of urinary protein is detected as having or not. A qualitative value indicating that is stored. In addition to such information, the patient DB 221 may be configured to include information on other patient's personal information, drug information, and clinical test value information.

Further, the clinical test value DB 222 will be described with reference to FIG. The clinical test value DB 222 is a DB having a relationship table for storing the relationship between the type and value of the drug and the clinical test value and a normal value table for storing the normal value of the clinical test value. In the relationship table, "drug" which is information on the drug, "clinical test value item" which stores the type of clinical test value, "clinical test value" which stores the value of the clinical test value, and the drug and the clinical test value The "relationship", which is the relationship between the type and the value, is memorized. The clinical test values and their normal values are stored in the normal value table.
In addition to such information, the clinical test value DB 222 may be configured to include other information regarding the relationship between the drug and the clinical test value. The normal value table may be configured to have normal values that differ depending on gender, age, and the like.
Here, the "relationship" is specifically information indicating what kind of relationship the clinical laboratory test value has for the drug. For example, the clinical test value of systolic blood pressure for the drug A, which is an antihypertensive drug A, is "relationship". Information that the relationship is "the effect of the drug" is stored. Further, for example, information that the clinical test value of γ-GTP is related to the “side effect of the drug” for the drug A of the antihypertensive drug is stored. Further, such a relationship is not limited to the effect and side effect of the drug, and may have three or more relationships. For example, the clinical test value of pulse for the drug A, which is an antihypertensive drug, is "the effect of the drug (not applicable)". A relationship such as "" may be provided. Here, off-label means to use for the purpose of symptoms not included in the approval content of the drug.
Further, the "relationship" may be configured so that the relationship changes depending on the value even if the same drug and the type of clinical laboratory test value are used. For example, while the information that the clinical test value of systolic blood pressure for a drug called antihypertensive drug A is related to the "effect of the drug" is stored, if the value of systolic blood pressure is "100 mgHG or less", "drug". Information that the relationship is "side effects of" is also stored. In this case, regarding the antihypertensive agent A, if the systolic blood pressure exceeds 100 mgHG, the systolic blood pressure is classified only as "effect of the drug", but if the systolic blood pressure is 100 mgHG or less, the systolic blood pressure is "effect of the drug" and Classified as "drug side effects".

In addition, the package insert DB 223 will be described with reference to FIG. In the package insert DB 223, the data of the package insert of the drug is stored in association with the drug for each item. The package insert is a product information description document for doctors and medical institution personnel that describes the drug name, precautions for use, item specifications, and other important matters for drugs. In the package insert DB 223, in addition to the drug name, information such as indications of indications and dosages, precautions for use, side effects, etc. is stored corresponding to the items of the package insert. Further, although not particularly shown, in addition to the information described in the package insert, items other than the package insert such as long-term administration check drug and high-risk drug may be provided.

The grouping means 213 groups the clinical laboratory test values for each drug based on the relationship between the drug and the clinical laboratory test value extracted by the extraction means 212.
Here, the reason why the grouping means 213 groups the clinical laboratory test values for each drug will be described. When dispensing to a patient, the condition of the patient's injury or illness in order to perform a prescription audit to confirm whether there is any doubt about delivering the drug as it is based on the items described in the prescription, patient information, drug history, etc.・ Clinical laboratory test values that can grasp the effects of the drug being taken may be referred to. However, there are many laboratory test values, and even if all the clinical test values for which information was obtained are displayed at the time of prescription audit, clinical test values that are not affected by the prescribed drug are also included. There is. In this way, if the clinical laboratory test values that do not affect the administration of the drug are displayed, the clinical laboratory test values that should be grasped at the time of prescription audit may not be grasped, or it may take time to grasp them. In addition, even if the clinical test values are affected by taking the drug, if the clinical test values related to the effects of the drug and the clinical test values related to the side effects of the drug are mixed, the pharmacist will set the clinical test values when conducting a prescription audit. I can't grasp it intuitively.
Therefore, the display device 2 that displays the clinical test values displays the clinical test values affected by the drug, and groups and displays the clinical test values based on the relationship between the drug and the clinical test value for each drug. Do.

Specifically, the process in which the grouping means 213 groups the clinical test values for each drug based on the relationship between the drugs and the clinical test values will be illustrated and described. In the present embodiment, for example, the grouping means 213 describes the extracted clinical test values of the patient's instep, systolic blood pressure, pulse, γ-GTP, and blood glucose level, and in the drug A, the systolic blood pressure, diastolic blood pressure, and pulse are “drugs”. Group as "effect of". In addition, since the systolic blood pressure of the patient A is 90 mgHG, the systolic blood pressure and γ-GTP are grouped as "side effects of the drug" in the drug A.
Here, the systolic blood pressure, diastolic blood pressure, and pulse are grouped in the same group as the "drug effect", but the relationship between drug A and the pulse is "drug effect (not indicated)", so the systolic blood pressure. And the diastolic blood pressure may be defined as "drug effect" and the pulse may be defined as "drug effect (not indicated)" as a group different from "drug effect".

The display means 214 groups the clinical test values based on the prescription contents and clinical test values received by the reception means 211 and the clinical test values and relationships extracted by the extraction means 212, and each clinical test value is a drug and clinical test. Data on the display screen configured so as to be distinguishable for each relationship with the inspection value is generated and displayed on the display unit 24. In addition, the display means 214 displays the dosing period of the drug based on the received prescription contents and the past prescription contents extracted by the extraction means 212. Further, the display means 214 limits the clinical test values related to the drug according to the acceptance of the selection of the displayed drug from the input unit 23, groups the clinical test values, and each clinical test value is a drug. Data on the display screen configured to be distinguishable for each relationship with the clinical test value is generated and displayed on the display unit 24.

Here, the display screen data displayed on the display unit 24 by the display means 214 will be described with reference to FIG. 7. FIG. 7 is a diagram showing that the display screen data generated by the display means 214 is displayed on the display unit 24, and the displayed screen is a prescription audit of the prescription for the patient “A” by the pharmacist “Totaro”. This is an example of a display screen displayed when the pharmacist "Taro Totaro" selects "Drug A" when performing the above. The pharmacist refers to this screen to perform a prescription audit and confirm the prescription contents based on the items described in the prescription, patient information / drug history, and clinical laboratory test values.

The display area V1 is a screen illustrating the period of taking the prescribed drug. In the display area V1, the date is displayed on the horizontal axis, and the contents of the prescription received by the receiving means 211 and the drugs prescribed in the past are displayed on the vertical axis. Then, a bar indicating the period during which the drug was prescribed is displayed in the central part. For example, B1 indicates that drug B is prescribed for 7 days from May 1st. In addition, if the period of taking the prescribed drug and the period of taking the drug of the prescription before and after it overlap, the bar will be shifted up and down and displayed so that the bars do not overlap, and the period of administration will be longer. A bar indicating it is displayed below the overlapping period. For example, like B2, the bar showing the 21-day drug A prescribed on April 16 is shifted up, and the bar showing the 30-day drug A prescribed on May 1 is down. It has become misaligned, and a bar indicating duplication is displayed during the period from May 1st to May 6th.
The drugs displayed in the display area V1 are adapted to display the clinical test values for the selected drug in the display area V2, which will be described later, in response to the acceptance of selection.

In the display areas V2, V3 and V4, the clinical laboratory test values of the prescribed drug are displayed in a distinguishable manner. V2, V3, and V4 of FIG. 7 accept the selection of the drug A, and the clinical laboratory test values for the drug A are displayed in a distinguishable manner for each relationship.
In the display area V2, the clinical laboratory test value whose relationship with the drug A is the "effect of the drug" is displayed. For example, in the display area V2, the systolic blood pressure, the diastolic blood pressure, and the pulse rate, whose relationship with the drug A is the “effect of the drug”, are displayed as the same group. Further, in the display area V3, a clinical test value whose relationship with the drug A is a "side effect of the drug" is displayed. For example, systolic blood pressure, γ-GTP, and urinary protein whose relationship with drug A is “side effect of drug” are displayed as the same group. The systolic blood pressure displayed in "Side effects of drugs" is displayed in "Side effects of drugs" because the value on May 1 is 100 or less, but when the value of systolic blood pressure is 100 or less. Without it, systolic blood pressure would not be displayed in "drug side effects".

The display area V4 accepts the selection of the drug A and displays the clinical laboratory test values that are not related to the drug A. For example, fasting blood glucose and HbA1C, which drug A does not affect, are displayed as the same group.

Graphs showing changes in clinical laboratory test values are displayed in the display areas V2, V3, and V4. The horizontal axis of the graph shows the month and day, and the vertical axis of the graph shows the values of clinical laboratory test values. In addition, the normal value range indicating the normal value of the clinical test value is shown in the center of the graph, and the quantitative clinical test value is displayed as a diagram so that the value of the clinical test value is displayed as a diagram. It has become. In addition, the qualitative clinical test value is displayed as +-so that the presence or absence thereof can be known.
Here, the month and day on the horizontal axis can be changed by pressing the enlargement or reduction button of the scale, and can be changed from the daily unit to the weekly unit, monthly unit, or the like. Further, the clinical test value on the vertical axis is a scale unit on the vertical axis so that the normal value of the clinical test value displayed from the clinical test value DB 222 is extracted and the range of the normal value of each clinical test value is the same. Is adjusted and displayed. For example, the systolic blood pressure, diastolic blood pressure, and pulse displayed on V3 are 100-129, 60-79, and 50-90, respectively, and the normal value ranges are displayed vertically so as to be displayed in the normal value range in the graph. The values of the axis scale (lower limit of scale, interval of scale and upper limit of scale) are adjusted so as to be different for each clinical laboratory test value.

As described above, the necessity of the vertical axis so that the normal value range display is the same will be described with reference to the simplified FIG.
In V5 of FIG. 8, the systolic blood pressure and the diastolic blood pressure are displayed, but the scales of the respective clinical test values are displayed so as to be the same, and the normal value range display is displayed differently. However, when displayed in this way, there is a problem that it is difficult to intuitively understand which clinical test value range corresponds to the diagram, and such a problem is caused by the type of clinical test value. The more you increase, the more difficult it is to understand intuitively.
Therefore, in the display device 2 for displaying the clinical test values, the scale values are adjusted so that the normal value range is the same range for different types of clinical test values.
The display of FIG. 7 and the display of FIG. 8 may be switched between each other by accepting the user's selection.

[Operation of display device 2 that displays clinical test values]
Subsequently, the operation of the display device 2 for displaying the clinical test value will be described with reference to FIG.
First, the receiving means 211 receives the prescription content and / and the clinical test value (step S1). After that, the reception means 211 associates the received prescription content and / and the clinical test value with the patient ID and stores it in the patient DB 221 (step S2). After that, the extraction means 212 extracts information on the past prescription contents and clinical test values necessary for generating the display image data, the relationship between the drug and the clinical test values, and the like (step S3). After that, the grouping means 213 groups the clinical test values for each drug based on the relationship between the drug and the clinical test value extracted by the extraction means 212 (step S4). After that, the display means 214 groups the clinical test values based on the prescription contents and clinical test values received by the reception means 211, and the clinical test values and relationships extracted by the extraction means 212, and each clinical test value is a drug. The data of the display screen configured so as to be distinguishable according to the relationship between the test value and the clinical test value is generated (step S5). After that, the display means 214 outputs the generated display screen data to the display unit 24 (step S6).

After that, the receiving means 211 accepts the selection of the drug (step S7). After that, the display means 214 generates display screen data limited to clinical test values related to the selected drug in response to the reception means 211 accepting the selection of the drug (step S8). After that, the display means 214 outputs the generated display screen data to the display unit 24 (step S9).

As described above, in the present embodiment, the clinical test values that the prescribed drug does not affect are not displayed, but only the clinical test values related to the prescribed drug are displayed. Therefore, the pharmacist is prescribed. It is possible to appropriately grasp the efficacy and side effects of the drug, and to efficiently grasp the information necessary for prescription audit of the prescription prescribed to the patient.

Further, in the present embodiment, the clinical test values that the prescribed drug does not affect are not displayed, but only the clinical test values related to the prescribed drug are displayed. Therefore, the pharmacist depends on the prescribed drug. It is possible to appropriately grasp the efficacy and side effects, and efficiently grasp the information necessary for prescription audit of prescriptions prescribed to patients.

Further, in the present embodiment, among the prescribed drugs, the clinical test values that the drug selected by the pharmacist does not affect are not displayed, and only the clinical test values related to the drug selected by the pharmacist are displayed. Therefore, the pharmacist can properly understand which of the prescribed drugs affects the clinical laboratory test values and causes efficacy and side effects, and can be used for prescription audit of the prescription prescribed to the patient. You can efficiently grasp the necessary information.

Further, in the present embodiment, the clinical test values that the prescribed drug does not affect are not displayed, but only the clinical test values related to the prescribed drug are displayed, and the relationship is determined by the values of the clinical test values. Is displayed differently, so pharmacists can intuitively understand the meaning of the displayed laboratory test values among the prescribed drugs, and efficiently streamline the information required for prescription audits for prescriptions prescribed to patients. Can be grasped.

[Second Embodiment]
In the first embodiment, the display device 2 has the reception means 211, the extraction means 212, the grouping means 213, and the display means 214 in the control unit 21, and the patient DB 221 and the patient DB 221 in one area of the storage unit 22. , The clinical laboratory test value DB222 and the package insert DB223.
On the other hand, in the present embodiment, as shown in FIG. 10, the control unit 21 has reception means 211a, extraction means 212, grouping means 213, display means 214a, and display switching reception means 215. In one area of the storage unit 22, the patient DB 221a, the clinical laboratory test value DB 222, and the package insert DB 223 are provided.
The functional configuration of this embodiment will be described below. The description of the same functions as those in the first embodiment will be omitted.

The reception means 211a accepts the content of the prescription at the time of a specific visit of the patient, the place where the patient's clinical test value and the clinical test value are acquired, and the place where the prescription content, the clinical test value and the clinical test value are acquired in association with the patient ID. Is stored in the patient DB 221a.
The reception means 211a determines the place where the clinical test value is obtained, such as whether the subject who acquired the clinical test value is a medical institution or a patient, or if the subject who acquired the clinical test value is a medical institution, what kind of medical institution is it. Accept indistinguishable.

In addition, the patient DB221a will be described with reference to FIG. The patient DB 221a is a DB that stores the prescription contents and clinical test values received at the pharmacy, and stores the prescription contents and clinical test values received by the reception means 211 in association with the patient ID. The patient DB221a has a "patient ID" that stores information that identifies the patient, a "patient name" that stores the patient's name, a "reception date" that stores the date when the prescription was accepted, and a prescription that is the content of the accepted prescription. In addition to the "drug" that stores the received drug, the "clinical test value item" that stores the type of clinical test value received, and the "clinical test value" that stores the value of the received clinical test value, "clinical" It is configured to have a "place of acquisition of inspection".

Returning to FIG. 10, the display switching receiving means 215 accepts the display method of the clinical test value, and displays the display of the clinical test value according to the accepted display method on the display unit 24.
Specifically, the display switching receiving means 215 accepts a method of displaying clinical test values. The method of displaying the clinical test value is a method of displaying whether or not to display the clinical test value separately according to the place where the clinical test value is obtained. When displaying the clinical test values separately, the method of distinction is selected. For the display method of clinical laboratory test values, for example, select one of "not distinguish", "distinguish / change the display depending on the location", "distinguish / display only medical institutions", and "distinguish / display only at home". Accept.

The display means 214a groups the clinical test values based on the prescription contents and clinical test values received by the reception means 211 and the clinical test values and relationships extracted by the extraction means 212, and each clinical test value is a drug and clinical test. Data on the display screen configured so as to be distinguishable for each relationship with the inspection value is generated and displayed on the display unit 24. The display means 214a displays the clinical test value according to the display method received by the display switching reception means 215.

Here, the display screen data displayed on the display unit 24 by the display means 214a will be described with reference to FIG. FIG. 12 is a diagram showing that the display screen data generated by the display means 214a is displayed on the display unit 24. The points in common with the first embodiment will be briefly described.

FIG. 12 (1) is display data generated by the display means 214a when the display switching reception means 215 receives “no distinction”.
Since "no distinction" was selected in the display area V2a, it is displayed as a diagram L1 regardless of the location where the clinical laboratory test value of systolic blood pressure was acquired.
FIG. 12 (2) is display data generated by the display means 214a when the display switching reception means 215 receives the message “distinguishing / changing the display depending on the location”.
In the display area V2a, since "distinguish / change display depending on location" is selected, the clinical laboratory test value of systolic blood pressure whose acquired location is α clinic is displayed as diagram L2, and the acquired location is home. Laboratory test values for systolic blood pressure are displayed as diagram L3.
FIG. 12 (3) is display data generated by the display means 214a when the display switching reception means 215 receives “distinguishing / displaying only medical institutions”.
In the display area V2a, since "distinguish / display only medical institutions" is selected, the clinical laboratory test value of systolic blood pressure at the α clinic is displayed as a diagram L4. The clinical laboratory test value of systolic blood pressure, which was obtained at home, is excluded from the diagram L4, but only the mark is displayed.

In this way, by displaying the clinical test values separately from the places where the clinical test values are obtained, it is possible to appropriately grasp the efficacy and side effects of the prescribed drug.
For example, systolic blood pressure may be measured by a healthcare professional to cause the patient to become tense and display a higher blood pressure than the original blood pressure. Therefore, the pharmacist can grasp the original hypertension by distinguishing and displaying the place where the systolic blood pressure is acquired.

As described above, in the present embodiment, the clinical test value can be displayed by distinguishing the place where the clinical test value is obtained. Therefore, the pharmacist should appropriately grasp the efficacy and side effects of the prescribed drug. It is possible to efficiently grasp the information necessary for prescription audit of the prescription prescribed to the patient.

The present invention is not limited to the above-described embodiment, and modifications, improvements, and the like within the range in which the object of the present invention can be achieved are included in the present invention.

Further, the present invention can be applied to a terminal device having the functional configuration shown in FIG. At this time, having the functional configuration shown in FIG. 3 means that the terminal device uses the software installed on the predetermined server via the network in addition to installing the software that realizes the functional configuration on the terminal device. Including possible states. That is, the present invention can also be applied to a so-called ASP service that provides a business application to a customer via the Internet.

Further, in the present embodiment, the clinical laboratory test value displayed by selecting the drug is displayed based on the group based on the relationship with the selected drug, but before accepting the selection, the clinical test value is displayed. Laboratory test values may be displayed based on the relationship with all drugs. In addition, by selecting the item of clinical laboratory test value or the diagram on the graph, it may be displayed that the drug having a relationship with the selected clinical laboratory test value is clarified. Here, the indication that the drug is clarified means that, for example, only the related drug may be displayed on the display unit, or the display color of the related drug is different from that of other drugs. It may be highlighted.

Further, in the present embodiment, clinical test values that are not related to the drug are displayed in the display area V4, but the present invention is not limited to this, and for example, clinical tests that are not related to the display area V4 are not provided. The inspection value may not be displayed.

Further, in the present invention, the clinical test value received by the receiving means 211 is not limited to which medical institution has acquired it. For example, it may be a clinical test value acquired at a pharmacy where the display device 2 is installed, or it may be a clinical test value acquired at a medical institution other than the pharmacy where the display device 2 is installed.
The clinical test values acquired by the reception means 211 at another medical institution are not limited to the clinical test values that the person in charge hears and inputs from the patient, and may be received from the other medical institution via the network line.

The series of processes described above can be executed by hardware or software.
In other words, the functional configuration of FIG. 3 is merely an example and is not particularly limited. That is, it suffices if the computer is provided with a function capable of executing the above-mentioned series of processes as a whole, and what kind of functional block is used to realize this function is not particularly limited to the example of FIG.
Further, one functional block may be configured by a single piece of hardware, a single piece of software, or a combination thereof.

When a series of processes are executed by software, the programs constituting the software are installed on a computer or the like from a network or a recording medium.
The computer may be a computer embedded in dedicated hardware. Further, the computer may be a computer capable of executing various functions by installing various programs, for example, a general-purpose personal computer.

1 Administrator device 2 Display device that displays clinical test values 3 Display 21 Control unit 22 Storage unit 23 Input unit 24 Display unit 211 Reception means 212 Extraction means 213 Grouping means 214 Display means 221 Patient DB
222 Laboratory test value DB
223 Package insert DB

Claims (13)

The laboratory test value having at least one of a plurality of types of relationships, including the effect of the drug and the side effect of the drug, for a specific drug based on the drug described in the patient's prescription and the laboratory test value of the patient. Extraction means to extract
A display means for displaying at least one of a clinical test value extracted by the extraction means and a change in the clinical test value for the specific drug.
A display device for displaying clinical laboratory test values. For each drug described in the prescription, the display means extracts at least one of the clinical test value extracted by the extraction means and the change in the clinical test value from each of the drugs and the clinical test extracted by the extraction means. The display device for displaying the clinical test value according to claim 1, which displays the relationship with the test value in a distinguishable display form. A grouping means for grouping the laboratory test values based on the type of the relationship with the specific drug.
The display means is a display device for displaying the clinical test values according to claim 1 or 2, which displays the grouped clinical test values in a distinguishable manner for each group. In the grouping, one of the laboratory test values may be classified into a different group for each drug.
A display device for displaying the clinical test value according to claim 3. The grouping is performed for each effect of the drug and side effects of the drug.
A display device for displaying the clinical test value according to claim 3 or 4. The grouping may be classified into a group of side effects of the drug when the value of the laboratory test value is a predetermined value.
A display device for displaying the clinical test value according to claim 5. The display means receives the selection of the specific drug, the clinical test value having the relationship with the specific drug, and the clinical test having no relationship with the specific drug. Display the value and
A display device for displaying the clinical test value according to any one of claims 1 to 6. The display means displays the clinical test values separately at the place where the clinical test values are obtained.
A display device for displaying the clinical test value according to any one of claims 1 to 7. At least one of multiple relationships, including drug effects and side effects, to a particular drug transmitted from the terminal device, based on the drug stated in the patient's prescription and the patient's laboratory test values. And an extraction means for extracting the clinical test value having
A display information transmitting means for transmitting information for displaying at least one of a clinical test value extracted by the extraction means and a change in the clinical test value to the terminal device for the specific drug.
Server with. A method of displaying clinical laboratory test values performed by a display device.
The laboratory test value having at least one of a plurality of types of relationships, including the effect of the drug and the side effect of the drug, for a specific drug based on the drug described in the patient's prescription and the laboratory test value of the patient. Extraction steps and
For the specific drug, a display step for displaying at least one of the clinical test value extracted in the extraction step and the change in the clinical test value.
How to display laboratory test values, including. It is a method of displaying clinical laboratory test values executed by the server.
At least one of multiple relationships, including drug effects and side effects, to a particular drug transmitted from the terminal device, based on the drug stated in the patient's prescription and the patient's laboratory test values. And the extraction step of extracting the clinical test value having
A display information transmission step of transmitting information for displaying at least one of the clinical test value extracted by the extraction means and the change of the clinical test value to the terminal device for the specific drug.
How to display laboratory test values, including. On the computer
The laboratory test value having at least one of a plurality of types of relationships, including the effect of the drug and the side effect of the drug, for a specific drug based on the drug described in the patient's prescription and the laboratory test value of the patient. Extraction function to extract
For the specific drug, a display function for displaying at least one of the clinical test value extracted by the extraction function and the change in the clinical test value, and
A program that realizes. On the computer
At least one of multiple relationships, including drug effects and side effects, to a particular drug transmitted from the terminal device, based on the drug stated in the patient's prescription and the patient's laboratory test values. And the extraction function to extract the clinical test value having
A display information transmission function for transmitting information for displaying at least one of a clinical test value extracted by the extraction function and a change in the clinical test value to the terminal device for the specific drug.
A program that realizes.

Images